The efficacy and safety comparison of PD-1/PD-L1 antibody, chemotherapy and supportive treatment for pretreated advanced esophagogastric cancer: a network meta-analysis.
Sign Up to like & getrecommendations! Published in 2020 at "Annals of palliative medicine"
DOI: 10.21037/apm-19-670
Abstract: BACKGROUND Immunotherapy is important for the treatment of esophagogastric cancer. The purpose of this study is to compare the efficacy and safety of PD-(L)1 antibody, chemotherapy, and supportive treatment in the management of pretreated advanced… read more here.
Keywords: esophagogastric cancer; treatment; supportive treatment; antibody chemotherapy ... See more keywords